[LGND] YoY Quarter Result on 30-Jun-2016 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
04-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -187.21%
YoY- -124.46%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Revenue 24,987 90,043 27,995 19,521 18,418 10,608 9,580 17.31%
PBT -18,028 95,579 8,300 -9,644 22,292 1,241 3,804 -
Tax -3,609 22,419 2,242 -3,881 265 -47 110 -
NP -14,419 73,160 6,058 -5,763 23,564 1,592 6,091 -
Tax Rate - -23.46% -27.01% - -1.19% 3.79% -2.89% -
Total Cost 39,406 16,883 21,937 25,284 -5,146 9,016 3,489 49.76%
Ratio Analysis
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
NP Margin -57.71 81.25 21.64 -29.52 127.94 15.01 63.58 -
Per Share
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
EPS -0.74 3.45 0.29 -0.28 1.19 0.08 0.30 -
EPS Diluted -0.74 2.99 0.26 -0.28 1.11 0.07 0.30 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.